(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide

C26H34ClN3O5S — CID 10482286

IUPAC(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide
SMILESCS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2cnc(CCC3(O)CCOCC3)cn2)cc1Cl
InChIInChI=1S/C26H34ClN3O5S/c1-36(33,34)23-7-6-19(15-22(23)27)21(14-18-4-2-3-5-18)25(31)30-24-17-28-20(16-29-24)8-9-26(32)10-12-35-13-11-26/h6-7,15-18,21,32H,2-5,8-14H2,1H3,(H,29,30,31)/t21-/m1/s1
InChIKeyOQYHMFLYTKMGJW-OAQYLSRUSA-N
MW536.09 g/mol
LogP4.31
Rot. Bonds9

About (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide

(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide (PubChem CID 10482286) has the molecular formula C26H34ClN3O5S and a molecular weight of 536.09 g/mol. Its IUPAC name is (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide.

Molecular Properties

Compound Name(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide
PubChem CID10482286
Molecular FormulaC26H34ClN3O5S
Molecular Weight536.09 g/mol
Exact Mass535.19
IUPAC Name(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide
SMILESCS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2cnc(CCC3(O)CCOCC3)cn2)cc1Cl
InChIInChI=1S/C26H34ClN3O5S/c1-36(33,34)23-7-6-19(15-22(23)27)21(14-18-4-2-3-5-18)25(31)30-24-17-28-20(16-29-24)8-9-26(32)10-12-35-13-11-26/h6-7,15-18,21,32H,2-5,8-14H2,1H3,(H,29,30,31)/t21-/m1/s1
InChIKeyOQYHMFLYTKMGJW-OAQYLSRUSA-N
XLogP4.31
TPSA118.48 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500536.09
LogP ≤ 54.31
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide?
The IUPAC name of (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide (CID 10482286) is (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide.
What is the SMILES notation for (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide?
The canonical SMILES for (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide is CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)Nc2cnc(CCC3(O)CCOCC3)cn2)cc1Cl.
What is the InChIKey of (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide?
The InChIKey is OQYHMFLYTKMGJW-OAQYLSRUSA-N. The full InChI is InChI=1S/C26H34ClN3O5S/c1-36(33,34)23-7-6-19(15-22(23)27)21(14-18-4-2-3-5-18)25(31)30-24-17-28-20(16-29-24)8-9-26(32)10-12-35-13-11-26/h6-7,15-18,21,32H,2-5,8-14H2,1H3,(H,29,30,31)/t21-/m1/s1.
What are the key properties of (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide?
(2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide has a molecular weight of 536.09 g/mol, XLogP of 4.31, 9 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-cyclopentyl-N-[5-[2-(4-hydroxyoxan-4-yl)ethyl]pyrazin-2-yl]propanamide is sourced from PubChem (CID 10482286), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).